Review of docetaxel in the treatment of gastric cancer

Eric D Tetzlaff1, Jonathan D Cheng1, Jaffer A Ajani21Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA; 2Gastrointestinal Medical Oncology, M.D. Anderson Cancer Center, Houston, TX, USAAbstract: Gastric cancer is a global health problem accounting for 800,000 cancer related deaths ann...

Full description

Saved in:
Bibliographic Details
Main Authors: Eric D Tetzlaff (Author), Jonathan D Cheng (Author), Jaffer A Ajani (Author)
Format: Book
Published: Dove Medical Press, 2008-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_376c7abcc1dd4459b37e75a09a2e311c
042 |a dc 
100 1 0 |a Eric D Tetzlaff  |e author 
700 1 0 |a Jonathan D Cheng  |e author 
700 1 0 |a Jaffer A Ajani  |e author 
245 0 0 |a Review of docetaxel in the treatment of gastric cancer 
260 |b Dove Medical Press,   |c 2008-09-01T00:00:00Z. 
500 |a 1176-6336 
500 |a 1178-203X 
520 |a Eric D Tetzlaff1, Jonathan D Cheng1, Jaffer A Ajani21Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA; 2Gastrointestinal Medical Oncology, M.D. Anderson Cancer Center, Houston, TX, USAAbstract: Gastric cancer is a global health problem accounting for 800,000 cancer related deaths annually. Often diagnosed at an advanced stage, the treatment of gastric cancer with chemotherapy is directed towards palliating cancer related symptoms with only modest improvements in survival. In addition, no regimen has emerged as a globally accepted standard. New therapeutic options are desperately needed for the treatment of gastric cancer. Docetaxel given in combination has recently emerged as a new option for patients with advanced gastric cancer. This review focuses on the treatment of advanced gastric cancer utilizing docetaxelbased therapy and the novel additions of biotherapy to the existing cytotoxic platforms. In addition, the current investigations of docetaxel for the treatment of potentially curable gastric cancer will be discussed.Keywords: docetaxel, gastric cancer, chemotherapy, biotherapy 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 5, Pp 999-1007 (2008) 
787 0 |n http://www.dovepress.com/review-of-docetaxel-in-the-treatment-of-gastric-cancer-a2160 
787 0 |n https://doaj.org/toc/1176-6336 
787 0 |n https://doaj.org/toc/1178-203X 
856 4 1 |u https://doaj.org/article/376c7abcc1dd4459b37e75a09a2e311c  |z Connect to this object online.